$IDRA Insider buying, Low float, high rel vol w/ a large gap

NASDAQ:IDRA   Idera Pharmaceuticals, Inc
$IDRA Recent insider buying, a bullish indication. Big news may be released soon. Mutli-phase trials of Tilsotolimod. ILLUMINATE-206 phase 2 results expected soon. Low float and high rel vol w/ a large gap to fill.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.